Report Code : CVMI24072747 | Published Date : July 16, 2024
Market Overview:
The European clinical nutrition market is undergoing a significant transformation, driven by an aging population, a rise in the burden of chronic diseases, and increased awareness of malnutrition in clinical settings. Hospitals in Germany, France, the UK, Italy, and the Netherlands are actively integrating nutrition into patient recovery pathways. Additionally, home-based enteral and parenteral nutrition services are expanding across the continent, supported by national health insurance programs and digital monitoring technologies.
Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2019 |
11.8 |
Covers both hospital-based and home-administered nutrition solutions |
2024 |
17.6 |
CAGR 8.4% (2019–2024); driven by elderly care and cancer nutrition protocols |
2031 |
26.4 |
CAGR 5.9% (2024–2031); digital support tools and renal/GI formulations rise |
Market Drivers
- Aging demographic in Western and Southern Europe necessitating tailored nutritional support
- Implementation of standardized screening tools (MUST, NRS-2002) across hospital systems
- Rise in cancer, diabetes, renal, and gastrointestinal disease cases requiring therapeutic nutrition
- EU-wide guidelines encouraging perioperative and ICU-specific nutritional interventions
- Strong R&D and manufacturing presence of firms like Fresenius Kabi, Nestlé Health Science, and Danone Nutricia
Market Challenges
- Public hospital budget constraints limiting advanced nutrition product access
- Regulatory variation between EU member states for product approval and reimbursement
- Low nutritional screening rates in outpatient and rehabilitation care
- Cultural differences in adoption of tube feeding and parenteral nutrition at home
Competitive Landscape
Company |
2024 Share |
Key Focus Areas |
Recent Developments |
Nestlé Health Science |
22% |
Adult enteral, GI, and oncology nutrition |
Launched GI Protect+ in EU (Q1 2025) |
Danone Nutricia |
20% |
Renal, pediatric, and home nutrition solutions |
New renal-focused blends in Italy & Germany (2024) |
Fresenius Kabi |
17% |
Parenteral nutrition, ICU, and oncology |
Expanded lipid-based IV product line (Q2 2025) |
Abbott |
13% |
Oral supplements for cancer & post-op care |
Piloted AI-personalized ONS in UK NHS (2024) |
Others (Baxter, B. Braun, regional players) |
28% |
Pediatric, diabetes nutrition, hospital tenders |
Localization efforts across CEE and Iberia |
Market Segmentation
By Route of Administration:
- Enteral Nutrition (EN) – 53%
- Parenteral Nutrition (PN) – XX%
- Oral Nutritional Supplements (ONS) – XX%
By End User:
- Hospitals and Acute Care Centers – 50%
- Home Healthcare & Long-Term Care – XX%
- Specialized Outpatient Clinics – XX%
Regional Spotlight
- Germany & France – Lead in ICU- and post-surgical nutrition protocols
- UK – National malnutrition screening implementation in NHS; digital dietetic tools scaling
- Italy & Spain – Growth in cancer and elderly home nutrition programs
Recent Developments
- Danone launched Nutrison Renal Advance for hospital and home renal patients (2024)
- Fresenius introduced EU-certified triple-chamber PN bags for ICU patients
- Nestlé deployed MySupport+ remote nutrition adherence app across EU5 (Q2 2025)
Strategic Outlook:
European health systems must ensure seamless nutritional support across both acute and home settings. Digital dietetic solutions, localized production of therapeutic blends, and unified EU reimbursement policies are essential for long-term adoption and access.
Reasons To Buy

Scope

Key Players
- estlé Health Science
- Danone Nutricia
- Abbott Laboratories
- Fresenius Kabi AG
- B. Braun Melsungen AG
- Baxter International Inc.
- Reckitt Benckiser Group plc
- Otsuka Holdings Co., Ltd.
- Bayer AG
- Pfizer Inc.
- Mead Johnson & Company, LLC
- BASF SE
- Perrigo Company plc
- DSM
- Nutricia Advanced Medical Nutrition
Clinical Nutrition Market Report
- 1. Clinical Nutrition Market Research Report
- 1.1 Study Objectives
- 1.2 Clinical Nutrition Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Clinical Nutrition Market Research Report - Preface
- 2.1 Clinical Nutrition Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Route of Administration:
- 2.1.2 By End User:
- 2.1.3 By Region
- 2.1 Clinical Nutrition Market Research Report – Detailed Scope and Definitions
- 3. Clinical Nutrition Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Route of Administration:, By End User:, By Country
- 3.3. Opportunities – By Route of Administration:, By End User:, By Country
- 3.4. Trends – By Route of Administration:, By End User:, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Clinical Nutrition Market Research Report – DROTs Impact Analysis
-
- 4. Clinical Nutrition Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Clinical Nutrition Market, By Route of Administration:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Enteral Nutrition (EN)
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Parenteral Nutrition (PN)
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Oral Nutritional Supplements (ONS)
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Hospitals and Acute Care Centers
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Home Healthcare & Long-Term Care
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Specialized Outpatient Clinics
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7. Clinical Nutrition Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 7.1 Europe
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Europe
- 8. Europe Clinical Nutrition Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 8.1 By Route of Administration: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 8.1.1 Enteral Nutrition (EN)
- 8.1.2 Parenteral Nutrition (PN)
- 8.1.3 Oral Nutritional Supplements (ONS)
- 8.2.1 Hospitals and Acute Care Centers
- 8.2.2 Home Healthcare & Long-Term Care
- 8.2.3 Specialized Outpatient Clinics
- 8.3.1 Germany
- 8.3.2 United Kingdom
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Europe Clinical Nutrition Market – Opportunity Analysis Index, By Route of Administration:, By End User:, and Country, 2024 - 2031
- 8.5 Regional Trends Analysis
- 8.6 Europe Clinical Nutrition Market Research Report - Company Profiles
- 8.6.1 Company 1 (Germany)
- 8.6.2 Company 2 (United Kingdom)
- 8.6.3 Company 3 (United Kingdom)
- 9.1 Strategic Dashboard of Top Market Players
- 9.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 9.2.1 Nestlé Health Science
- 9.2.2 Danone Nutricia
- 9.2.3 Abbott Laboratories
- 9.2.4 Fresenius Kabi AG
- 9.2.5 B. Braun Melsungen AG
- 9.2.6 Baxter International Inc.
- 9.2.7 Reckitt Benckiser Group plc
- 9.2.8 Otsuka Holdings Co. Ltd.
- 9.2.9 Bayer AG
- 9.2.10 Pfizer Inc.
- 9.2.11 Mead Johnson & Company LLC
- 9.2.12 BASF SE
- 9.2.13 Perrigo Company plc
- 9.2.14 DSM Nutritional Products
- 9.2.15 Nutricia Advanced Medical Nutrition
- 8.1 By Route of Administration: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10. Data Collection Method and Research Approach
- 11. Principal Presumptions and Acronyms